J. Sobel and . Botulism, Botulism, Clinical Infectious Diseases, vol.178, issue.1, pp.1167-1173, 2005.
DOI : 10.1086/515615

Y. Fujinaga, Y. Sugawara, and T. Matsumura, Uptake of Botulinum Neurotoxin in the Intestine, Curr Top Microbiol Immunol, vol.364, pp.45-59, 2013.
DOI : 10.1007/978-3-662-45790-0_3

J. Barash and S. Arnon, A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins, The Journal of Infectious Diseases, vol.285, issue.2, pp.183-191, 2014.
DOI : 10.1001/jama.285.8.1059

N. Dover, J. Barash, K. Hill, G. Xie, and S. Arnon, Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene, The Journal of Infectious Diseases, vol.235, issue.2, pp.192-202, 2014.
DOI : 10.1111/j.1574-6968.2004.tb09561.x

S. Maslanka, C. Lúquez, J. Dykes, W. Tepp, C. Pier et al., A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin, Journal of Infectious Diseases, vol.32, issue.3, pp.379-385, 2016.
DOI : 10.1093/infdis/150.3.407

A. Wheeler and H. Smith, Botulinum toxins: Mechanisms of action, antinociception and clinical applications, Toxicology, vol.306, pp.124-146, 2013.
DOI : 10.1016/j.tox.2013.02.006

J. Weber, R. Hibbs, A. Darwish, B. Mishu, A. Corwin et al., A Massive Outbreak of Type E Botulism Associated with Traditional Salted Fish in Cairo, Journal of Infectious Diseases, vol.167, issue.2, pp.451-454, 1993.
DOI : 10.1093/infdis/167.2.451

R. Hibbs, J. Weber, A. Corwin, B. Allos, A. El-rehim et al., Experience with the Use of an Investigational F(ab')2 Heptavalent Botulism Immune Globulin of Equine Origin During an Outbreak of Type E Botulism in Egypt, Clinical Infectious Diseases, vol.23, issue.2, pp.337-340, 1996.
DOI : 10.1093/clinids/23.2.337

K. Jalava, K. Selby, A. Pihlajasaari, E. Kolho, E. Dahlsten et al., Two cases of food-borne botulism in Finland caused by conserved olives, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011.

J. Pingeon, C. Vanbockstael, M. Popoff, L. King, B. Deschamps et al., Two outbreaks of botulism associated with consumption of green olive paste, France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011.

B. Raphael, T. Shirey, C. Lúquez, and S. Maslanka, Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains, BMC Microbiology, vol.14, issue.1, p.25031122, 2014.
DOI : 10.1186/1471-2180-14-192

A. Gupta, C. Sumner, M. Castor, S. Maslanka, and J. Sobel, Adult botulism type F in the United States, 1981-2002, Neurology, vol.65, issue.11, pp.1694-1700, 1981.
DOI : 10.1212/01.wnl.0000187127.92446.4c

G. Schiavo, M. Matteoli, and C. Montecucco, Neurotoxins Affecting Neuroexocytosis, Physiological Reviews, vol.267, issue.2, pp.717-766, 2000.
DOI : 10.1007/BF00498693

S. Arnon, R. Schechter, T. Inglesby, D. Henderson, J. Bartlett et al., Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-1070, 2001.
DOI : 10.1001/jama.285.8.1059

J. Froude, B. Stiles, T. Pelat, and P. Thullier, Antibodies for biodefense, mAbs, vol.2, issue.6, pp.517-527, 2011.
DOI : 10.4161/mabs.2.3.11416

URL : http://www.tandfonline.com/doi/pdf/10.4161/mabs.3.6.17621?needAccess=true

G. Bozheyeva, Y. Kunakbayev, and D. Yeleukenov, Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future, Montrerey Inst Int Stud.Occasional Paper, issue.1, 1999.

W. Broad, . Sowing, and . Death, How Japan Germ Terror Alerted World. The New York Times Available: http://www.nytimes.com/1998/05/26/world/sowing-death-a-special- report-how-japan-germ-terror-alerted-world.html, A special report, 1998.

L. Wein and Y. Liu, Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk, Proceedings of the National Academy of Sciences, vol.334, issue.20, pp.9984-9989, 2005.
DOI : 10.1056/NEJM199605163342001

R. Black and R. Gunn, Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-570, 1980.
DOI : 10.1016/0002-9343(80)90469-6

S. Long, Infant Botulism and Treatment With BIG-IV (BabyBIG??), The Pediatric Infectious Disease Journal, vol.26, issue.3, pp.261-262, 2007.
DOI : 10.1097/01.inf.0000256442.06231.17

S. Arnon, R. Schechter, S. Maslanka, N. Jewell, and C. Hatheway, Human Botulism Immune Globulin for the Treatment of Infant Botulism, New England Journal of Medicine, vol.354, issue.5, pp.462-471, 2006.
DOI : 10.1056/NEJMoa051926

C. Rasetti-escargueil, A. Avril, S. Chahboun, R. Tierney, N. Bak et al., Development of humanlike scFv-Fc antibodies neutralizing Botulinum toxin serotype B. mAbs, pp.1161-1177, 2015.

S. Miethe, C. Rasetti-escargueil, Y. Liu, S. Chahboun, T. Pelat et al., Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library, mAbs, vol.57, issue.2, pp.446-459, 2014.
DOI : 10.1038/2338

A. Avril, S. Miethe, M. Popoff, C. Mazuet, S. Chahboun et al., Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain, BMC Biotechnology, vol.53, issue.2, pp.86-26382731, 2015.
DOI : 10.1016/j.toxicon.2009.01.019

V. Ahmadzadeh, S. Farajnia, M. Feizi, and R. Nejad, Antibody Humanization Methods for Development of Therapeutic Applications, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, vol.33, issue.2, pp.67-73, 2014.
DOI : 10.1089/mab.2013.0080

T. Pelat and P. Thullier, Non-human primate immune libraries combined with germline humanization, mAbs, vol.146, issue.4, pp.377-381, 2009.
DOI : 10.1016/j.critrevonc.2007.04.011

P. Tan, D. Mitchell, T. Buss, M. Holmes, C. Anasetti et al., "Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 1950.
DOI : 10.4049/jimmunol.169.2.1119

G. Williams, C. Jolly, J. Köhler, and M. Neuberger, The Contribution of Somatic Hypermutation to the Diversity of Serum Immunoglobulin, Immunity, vol.13, issue.3, pp.409-417, 2000.
DOI : 10.1016/S1074-7613(00)00040-6

T. Pelat, H. Bedouelle, A. Rees, S. Crennell, M. Lefranc et al., Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering, Journal of Molecular Biology, vol.384, issue.5, pp.1400-1407, 2008.
DOI : 10.1016/j.jmb.2008.10.033

URL : https://hal.archives-ouvertes.fr/hal-00345933

R. Robert, V. Streltsov, J. Newman, L. Pearce, K. Wark et al., Germline humanization of a murine A?? antibody and crystal structure of the humanized recombinant Fab fragment, Protein Science, vol.2, issue.2, pp.299-308, 2010.
DOI : 10.1212/01.WNL.0000073623.84147.A8

C. Pommié, S. Levadoux, R. Sabatier, G. Lefranc, and M. Lefranc, IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties, Journal of Molecular Recognition, vol.17, issue.1, pp.17-32, 2004.
DOI : 10.1002/jmr.647

N. Whitelegg and A. Rees, WAM: an improved algorithm for modelling antibodies on the WEB, Protein Engineering, Design and Selection, vol.13, issue.12, pp.819-824, 2000.
DOI : 10.1084/jem.132.2.211

L. Rosenwasser, W. Busse, R. Lizambri, T. Olejnik, and M. Totoritis, Allergic asthma and an anti-CD23 mAb (IDEC-152) Results of a phase I, single-dose, dose-escalating clinical trial, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.563-570, 2003.
DOI : 10.1016/S0091-6749(03)01861-X

J. Byrd, O. Brien, S. Flinn, I. Kipps, T. Weiss et al., Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia, Clinical Cancer Research, vol.13, issue.15, pp.4448-4455, 2007.
DOI : 10.1158/1078-0432.CCR-06-1463

M. Hust, T. Meyer, B. Voedisch, T. Rülker, H. Thie et al., A human scFv antibody generation pipeline for proteome research, Journal of Biotechnology, vol.152, issue.4, p.20883731, 2011.
DOI : 10.1016/j.jbiotec.2010.09.945

P. Tan, D. Mitchell, T. Buss, M. Holmes, C. Anasetti et al., "Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 1950.
DOI : 10.4049/jimmunol.169.2.1119

R. Jones, T. Alsop, R. Hull, R. Tierney, P. Rigsby et al., Botulinum type A toxin neutralisation by specific IgG and its fragments: A comparison of mouse systemic toxicity and local flaccid paralysis assays, Toxicon, vol.48, issue.3, pp.246-254, 2006.
DOI : 10.1016/j.toxicon.2006.05.007

A. Nowakowski, C. Wang, D. Powers, P. Amersdorfer, T. Smith et al., Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proceedings of the National Academy of Sciences, vol.287, issue.5458, pp.11346-11350, 2002.
DOI : 10.1126/science.287.5458.1664

L. Cheng, L. Stanker, T. Henderson, J. Lou, and J. Marks, Antibody Protection against Botulinum Neurotoxin Intoxication in Mice, Infection and Immunity, vol.77, issue.10, pp.4305-4313, 2009.
DOI : 10.1128/IAI.00405-09

S. Adekar, T. Takahashi, R. Jones, F. Saleem, D. Ancharski et al., Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.18714390, 2008.
DOI : 10.1371/journal.pone.0003023.t002

C. Mazuet, J. Dano, M. Popoff, C. Créminon, and H. Volland, Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity, PLoS ONE, vol.13, issue.8, p.20865035, 2010.
DOI : 10.1371/journal.pone.0012416.s003

J. Prigent, C. Mazuet, D. Boquet, P. Lamourette, H. Volland et al., Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A, PLoS ONE, vol.328, issue.333, p.20967241, 2010.
DOI : 10.1371/journal.pone.0013245.t004

URL : https://hal.archives-ouvertes.fr/pasteur-01762123

S. Miethe, C. Rasetti-escargueil, A. A. Liu, Y. Chahboun, S. Korkeala et al., Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E, PLOS ONE, vol.384, issue.10, p.26440796, 2015.
DOI : 10.1371/journal.pone.0139905.s001

URL : https://hal.archives-ouvertes.fr/pasteur-01325687

E. Pettersen, T. Goddard, C. Huang, G. Couch, D. Greenblatt et al., UCSF Chimera?A visualization system for exploratory research and analysis, Journal of Computational Chemistry, vol.373, issue.13, pp.1605-1612, 2004.
DOI : 10.1002/jcc.20084

V. Jäger, K. Büssow, A. Wagner, S. Weber, M. Hust et al., High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells, BMC Biotechnol, vol.13, p.23802841, 2013.

S. Sibéril, C. Dutertre, C. Boix, E. Bonnin, R. Ménez et al., Molecular aspects of human Fc??R interactions with IgG: Functional and therapeutic consequences, Immunology Letters, vol.106, issue.2, pp.111-118, 2006.
DOI : 10.1016/j.imlet.2006.05.009

K. Tsuji, K. Steindler, and S. Harrison, Limulus amoebocyte lysate assay for detection and quantitation of endotoxin in a small-volume parenteral product, Appl Environ Microbiol, vol.40, pp.533-538, 1980.

A. Guttman, On the separation mechanism of capillary sodium dodecyl sulfate-gel electrophoresis of proteins, Electrophoresis, vol.7, issue.1, pp.611-616, 1995.
DOI : 10.1016/S0026-0495(64)80018-4

Z. Szabo, A. Guttman, J. Bones, and B. Karger, -Glycans by Capillary Electrophoresis, Analytical Chemistry, vol.83, issue.13, pp.5329-5336, 2011.
DOI : 10.1021/ac2007587

A. Razai, C. Garcia-rodriguez, J. Lou, I. Geren, C. Forsyth et al., Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A, Journal of Molecular Biology, vol.351, issue.1, pp.158-169, 2005.
DOI : 10.1016/j.jmb.2005.06.003

P. Schuck and A. Minton, Kinetic analysis of biosensor data: elementary tests for self-consistency, Trends in Biochemical Sciences, vol.21, issue.12, pp.458-460, 1996.
DOI : 10.1016/S0968-0004(96)20025-8

D. Sesardic, R. Jones, T. Leung, T. Alsop, and R. Tierney, Detection of antibodies against botulinum toxins, Movement Disorders, vol.101, issue.S8, pp.85-91, 2004.
DOI : 10.1016/S0041-0101(01)00288-4

V. Morineaux, C. Mazuet, D. Hilaire, J. Enche, and M. Popoff, Characterization of botulinum neurotoxin type A subtypes by immunocapture enrichment and liquid chromatography???tandem mass spectrometry, Analytical and Bioanalytical Chemistry, vol.330, issue.1???2
DOI : 10.1016/j.jim.2007.11.006